Chp Merger Corp (CHPMU) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chp Merger Corp   (CHPMU)


Chp Merger's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Chp Merger's ROI in the fourth quarter of 2021?
Chp Merger Corp achieved a return on average invested assets (ROI) of 119.41 % in its fourth quarter of 2021 a new company high.

Despite the deterioration in its net income, company has improved ROI compared to the third quarter of 2021.

Within the Healthcare sector 8 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from to 41.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM -8.45 % 2.56 % 35.77 % 102.21 % 304.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 185 301 302 292 303
Return On Investment (TTM) 119.41 % 107.75 % 104.77 % 103.37 % -4.67 %
CHPMU's Overall Ranking # 41 # # # #
Seq. Investment Change TTM -9.86 % 0.76 % 0.8 % -0 % 0.98 %
Seq. Net Income Change TTM -0.1 % 3.62 % 2.17 % - -
Net Income (TTM) in Millions 322 323 311 305 -14

CHPMU Company Profile >> Back to CHPMU Roi Comparisons >> See Annual CHPMU Return On Investment



Return On Investment CHPMU's Ranking
Within: No.
Industry # 2
Sector # 9
Overall # 41

Return On Investment Statistics
High Average Low
119.41 %
119.41 %
119.41 %
(Dec 31 2021)  







Financial Statements
Chp Merger's IV. Quarter Investments $ 185 Millions CHPMU's Balance sheet
Chp Merger's IV. Quarter Income $ 0 Millions Quarterly CHPMU's Income Statement
CHPMU's Income by Division See CHPMU's Income by Division


CHPMU Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions 185 303 0 0 0
Y / Y Investment Growth -39.02 % - - - -
Net Income in Millions 22 -24 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 12.04 % -8.09 % - - -


Annual Roi Comment
In the fiscal year 2021 ROI improved to 12.04 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CHPMU's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CHPMU's Competitors
Subscribers only: Roi for Chp Merger's Suppliers
Subscribers only: Return On Investment for CHPMU's Customers

Other Ratios
CHPMU's Roa CHPMU's Inventory Turnover Ratio CHPMU's Growth Rates CHPMU's Dividend Statistics
CHPMU's Profitability Ratios CHPMU's Asset Turnover Ratio CHPMU's Dividend Growth
CHPMU's Roe CHPMU's Valuation Ratios CHPMU's Financial Strength Ratios CHPMU's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Biovie Inc   288.24 %
Aceragen Inc   267.41 %
Procept Biorobotics Corporation  267.16 %
Lianbio  255.96 %
Notable Labs Ltd   188.79 %
Entrada Therapeutics Inc   154.28 %
Moderna Inc   128.20 %
Chp Merger Corp   119.41 %
Altamira Therapeutics Ltd   118.29 %
Omeros Corporation  117.05 %
Galmed Pharmaceuticals Ltd   105.45 %
Sinovac Biotech Ltd  93.85 %
Vyne Therapeutics Inc   93.73 %
Agios Pharmaceuticals Inc   90.82 %
Biontech Se  84.02 %
Vivos Therapeutics Inc   72.72 %
Ovid Therapeutics Inc   59.58 %
Carisma Therapeutics Inc   58.59 %
Glucotrack Inc   58.06 %
Biomx Inc  57.30 %
Ironwood Pharmaceuticals inc   55.38 %
Iteos Therapeutics Inc   54.32 %
Reflect Scientific Inc  52.07 %
Fulgent Genetics Inc   50.82 %
Silo Pharma Inc  50.34 %
Siga Technologies Inc  49.80 %
Uniqure N v   49.63 %
Vir Biotechnology Inc   49.45 %
Molecular Templates Inc   48.02 %
Biocept Inc   47.39 %

Date modified: 2026-08-30T05:22:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.